to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
What would you do if you were promised $24 million in funding – but the venture firm changed its mind?
Entrepreneurs are the cream of the crop – the best innovators in the economy. So why are such smart people overpaying for health insurance?
Healthcare innovators can benefit from a trio of grant awards from the National Institutes of Health. Read more about how the NIH is helping innovators in the life sciences field.
Life sciences business owners are seeing a modest rise in venture capital funds – no mean feat in this economy. But one big communications mistake will take you and your firm out of the running.
Can "boom and bust" cycles exist in the venture funding market? You bet they can. And recent data from the chemical sector is a great example of how and why.
There's stability and then there's outright growth. For healthcare business owners looking for angel funding, they'll have to accept the former and wait some more on the latter. But at least it's progress.
In a venture funding climate seeking large returns, thousands of potentially successful entrepreneurial startups can't get the financing they need to make a difference in the economy and in the culture. The problem isn't a new one, but it is a damaging one.
As year-end approaches and entrepreneurs regroup to figure out financing options for 2012, it's a good time to take a look at the two major sources of new business funding -- angel investing versus venture capital.
In Part Two of our look at early-stage entrepreneurial funding, we examine the pros and cons of the two primary startup funding mechanisms: venture capital and angel funding.
Local investing could be the answer to the problem of dealing with big banks and the way they do business. Read more about this funding alternative for startups.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.